# Anika Therapeutics, Inc.: Form 8-K, filed Nov 5, 2025

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: 8-K
- Filed: 2025-11-05
- Accepted by EDGAR: Nov 5, 2025, 07:20 ET
- Period: 2025-11-05
- Accession: 0001171843-25-007003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000117184325007003/f8k_110525.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000117184325007003/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000117184325007003/f8k_110525.htm

Filed Nov 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-007003. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.